GlaxoSmithKline (GSK)

Codexis Enters into Technology Collaboration with GSK

Topics • Strategy

Potential In Eastern Europe

New Corruption Allegations Against GSK From Syria

Glaxo-Linked Foreign Investigators Said Indicted

Sex Video is New Twist in GSK China Bribery Scandal

Adaptimmune in Cancer Collaboration With GlaxoSmithKline

GSK Invites Private Equity Bids for Older Drugs

Corruption Charges Against GSK Seen as Warning

Topics • Strategy

International Drugmakers Meet Challenges

Bayer to Pay $14.2 Billion for U.S. Merck’s Consumer Business

Novartis and GlaxoSmithKline Swap $20 Billion in Assets

GSK Faces Criminal Bribery Investigation in Poland

Amgen Ends Non-U.S. Co-Marketing Pact With GSK

GlaxoSmithKine Investigates Alleged Bribery in Iraq

GSK Combined Melanoma Treatment Delayed in Europe

GlaxoSmithKline Offer lifts Indian Stakeholding to 75%

Bayer, Novartis said to Eye Merck & Co consumer health unit

Facing Fines, Glaxo SmithKline to Stop Drug Promotion Excesses

Cameron Raises GSK’s Problems as CEO Joins Him On China Visit

Glaxo SmithKline to Invest in Scottish Plant expansion

GlaxoSmithKline India Hit By Drop In Bulk Orders

Astrazeneca CEO Gets Two Cheers after First Year in Job

AstraZeneca Looks for New Heart Drug Approval by Next May

GSK Cancer Drug Combination Wins US Priority Review

Teva to Drop Depression Treatment after Trial Fails

Amgen Buys Onyx for $10.4 Billion

Briton Peter Humphrey Arrested Amid Chinese Pharmaceuticals Probe

China to Launch Fresh Pharmaceutical Bribery Probe

China Investigates France's Sanofi for Alleged Bribery

Top Insulin Maker Novo Caught Up In China's Widening Drug Probes

GSK Plugs into Bioelectronics with $50 Million Venture Fund

European Companies Catch A Cold In Emerging Markets

India Revokes GSK Cancer Drug Patent In Latest Big Pharma Blow

Drug Makers Fear Short-Term Turmoil As China Probes Widen

AstraZeneca Warns Of Higher Costs As Drug Sales Slide

145 more articles

Top-Feature

Brenntag Downsizes Management Board, Retains Both Divisions

Dow Chemical Company

Anchored in Sustainability

CHEManager International c/o Wiley-VCH GmbH

API Manufacturing

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Easyfairs Deutschland GmbH

Leading the way. Driving results.

JMP Statistical Discovery / SAS Institute GmbH

From Data to Decisions: Digital Tools Reshaping the Chemical and Life Sciences Landscape

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

Leading Transformation

Interview

Driving Sustainability Through Collaboration

Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Oracle Germany

EvaluatePharma

Thermo Fisher Scientific

Chemical Market Reporter

GlaxoSmithKline (GSK) plc

Novo Nordisk A/S

Microinnova Engineering GmbH

ISPE D/A/CH e.V.

Society of Chemical Industry (SCI)

EDB Singapore

Thomson Reuters

Cincinnati USA Reg. Chamber

Novartis International AG

Sanofi S.A.